Company News

14 03, 2024

qPCR or ddPCR for Bioanalysis? – Download our Comprehensive Guide

2025-06-24T13:54:49+00:00

This comprehensive guide explores the essential tools of quantitative PCR (qPCR) and digital droplet PCR (ddPCR) in the biopharmaceutical industry, offering invaluable insights into their applications, strengths, and limitations. Download now to stay ahead of the curve in pharmaceutical research and development...

qPCR or ddPCR for Bioanalysis? – Download our Comprehensive Guide2025-06-24T13:54:49+00:00
10 03, 2024

Society of Toxicology (SOT) Annual Meeting – 2024

2025-06-24T14:26:26+00:00

We are thrilled to announce that Avance Biosciences™ will be attending the highly anticipated Society of Toxicology Annual Meeting in Salt Lake City, and we cordially invite you to join us! More than 5,000 toxicologists and those working in areas related to toxicology will share the latest science and technology...

Society of Toxicology (SOT) Annual Meeting – 20242025-06-24T14:26:26+00:00
27 11, 2023

Gene Therapy Analytical Development & mRNA Assay Development Summits – 2023

2025-06-24T14:26:26+00:00

We are excited to announce that Avance Biosciences™ will be attending the highly anticipated Gene Therapy Analytical Development Summit and the mRNA Assay Development Summit, and we cordially invite you to join us! As a leader in development and validation of  assays for advanced therapies...

Gene Therapy Analytical Development & mRNA Assay Development Summits – 20232025-06-24T14:26:26+00:00
30 10, 2023

CRISPR-Based Therapy Analytical Development Summit – 2023

2025-06-24T14:26:27+00:00

We are thrilled to announce that Avance Biosciences™ will be attending the highly anticipated CRISPR-Based Therapy Analytical Development Summit, and we cordially invite you to join us! As a leader in advanced therapies, we understand the importance of staying at the forefront of gene therapy innovation...

CRISPR-Based Therapy Analytical Development Summit – 20232025-06-24T14:26:27+00:00
19 09, 2023

BioProcess International – Cell & Gene Therapy Conference – 2023

2025-06-24T14:26:27+00:00

We are thrilled to announce that Avance Biosciences™ will be attending the highly anticipated Cell & Gene Therapy Manufacturing Conference, and we cordially invite you to join us! As a leader in advanced therapies, we understand the importance of staying at the forefront of cell and gene therapy innovation...

BioProcess International – Cell & Gene Therapy Conference – 20232025-06-24T14:26:27+00:00
29 08, 2023

Gene Therapy Potency Assay Summit – 2023

2025-06-24T14:26:27+00:00

We are thrilled to announce that Avance Biosciences™ will be attending the highly anticipated Gene Therapy Potency Assay Summit, and we cordially invite you to join us! As a leader in advanced therapies, we understand the importance of staying at the forefront of gene therapy innovation...

Gene Therapy Potency Assay Summit – 20232025-06-24T14:26:27+00:00
11 07, 2023

Enhancing Safety and Efficacy – Biodistribution Services for Advanced Cell and Gene Therapies

2025-06-24T14:33:19+00:00

As the field of advanced cell and gene therapies continues to grow exponentially, ensuring their safety and efficacy becomes paramount. Biodistribution studies, which evaluate the distribution of viral vectors and transgenes in the body, play a crucial role in pre-clinical pharmacokinetics and toxicity assessments...

Enhancing Safety and Efficacy – Biodistribution Services for Advanced Cell and Gene Therapies2025-06-24T14:33:19+00:00
31 05, 2023

Cell Therapy Potency Assay Summit – 2023

2025-06-24T14:26:28+00:00

Ensure the Success of Your Cell Therapy Drug Development - Avance Provides Assays to Support your Biopharmaceutical Development & Manufacturing - Avance Biosciences™ is a world-leading CRO specializing in GLP & GMP compliant biological assay development, assay validation, and [...]

Cell Therapy Potency Assay Summit – 20232025-06-24T14:26:28+00:00
9 05, 2023

NGS for ID and characterization of AAV genomes

2025-06-24T14:00:41+00:00

Adeno-associated virus (AAV) is a small, non-pathogenic, and non-enveloped virus that has become an important tool for gene therapy research and applications. AAV is a type of virus that requires a helper virus (such as adenovirus) to replicate, and it has a high degree of stability and safety, as it does not...

NGS for ID and characterization of AAV genomes2025-06-24T14:00:41+00:00
Go to Top